Stay updated with breaking news from Sciences Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exact Sciences Co. (NASDAQ:EXAS – Get Rating) shares reached a new 52-week high during trading on Tuesday . The stock traded as high as $86.00 and last traded at $85.49, with a volume of 477897 shares. The stock had previously closed at $84.95. Analysts Set New Price Targets EXAS has been the topic of several […]
Zevenbergen Capital Investments LLC lowered its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 6.8% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,385,328 shares of the medical research company’s stock after selling 100,920 shares during the period. Exact […]
MADISON, Wis., June 1, 2023 /PRNewswire/ -- Exact Sciences Corp. , a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the... | June 1, 2023
MDxHealth SA, a maker of noninvasive urology tests used to diagnose prostate cancer that’s struggled to gain traction as a public company (Nasdaq: MDXH), looks closer to turning an important corner.
Marco Investment Management LLC trimmed its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 0.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 80,533 shares of the medical research company’s stock after selling 700 shares during the quarter. Marco […]